title: The effects of octreotide in a patient with Nelson's syndrome.
abstract: We have administered octreotide, 100 micrograms tid, to a 27-year-old man with Nelson's syndrome. After seven days of therapy, adrenocorticotropin levels fell to 54% of initial values, and some shrinkage of the tumour was observed. This study indicates that octreotide therapy may have a role in the treatment of Nelson's syndrome.
authors: Department of Internal Medicine, Erciyes University Medical School, 38039 Kayseri-Turkey.
authors: F
authors: F
authors: Kelestimur
authors: C
authors: C
authors: Utas
authors: O
authors: O
authors: Ozbakir
authors: A
authors: A
authors: Selçuklu
authors: O
authors: O
authors: Kandemir
authors: N
authors: N
authors: Ozcan
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009347:Nelson Syndrome / Q000097:blood / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D000324:Adrenocorticotropic Hormone; D015282:Octreotide